Healthcare Realty Trust Incorporated financials
$17.94−0.22%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $278.6M | $275.3M | $282.7M | $294.3M | $294.1M | $295.2M | $305.7M | $311.5M | $312.5M | $322.3M | $326.0M | $338.0M |
| Gross profit | $179.6M | $175.2M | $172.0M | $180.8M | $189.9M | $185.3M | $191.3M | $191.3M | $194.7M | $201.2M | $204.7M | $206.4M |
| Gross margin | 64.5% | 63.7% | 60.8% | 61.4% | 64.6% | 62.8% | 62.6% | 61.4% | 62.3% | 62.4% | 62.8% | 61.1% |
| Operating income | $35.7M | $28.0M | $30.5M | $21.1M | $12.3M | $14.8M | -$4.8M | $7.2M | $6.8M | $7.9M | $10.3M | $1.8M |
| Net income | -$43.5M | -$56.0K | $14.4M | -$57.7M | -$157.9M | -$44.9M | -$106.8M | -$93.0M | -$143.8M | -$310.8M | -$43.9M | -$67.8M |
| Net margin | −15.6% | 0.0% | 5.1% | −19.6% | −53.7% | −15.2% | −35.0% | −29.9% | −46.0% | −96.5% | −13.5% | −20.1% |
| Diluted EPS | $-0.13 | $0.00 | $0.04 | $-0.17 | $-0.45 | $-0.13 | $-0.30 | $-0.26 | $-0.39 | $-0.82 | $-0.12 | $-0.18 |
| EBITDA | $185.3M | $161.2M | $165.1M | $163.9M | $180.6M | $170.7M | $160.1M | $176.1M | $186.7M | $189.7M | $10.0M | $222.7M |
| Operating cash flow | $142.2M | $52.9M | $132.3M | $113.8M | $163.2M | $47.8M | $138.0M | $119.3M | $168.2M | $76.2M | $127.3M | $118.2M |
| Free cash flow | $72.4M | -$8.3M | $45.8M | $20.5M | $72.8M | -$24.8M | $56.8M | $30.9M | $77.2M | $17.4M | $43.4M | $41.6M |
| Diluted shares | 342.3M | 347.4M | 350.1M | 350.0M | 349.6M | 349.5M | 351.3M | 359.0M | 372.5M | 379.5M | 379.0M | 378.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.0M | $26.2M | $26.2M | $43.3M | $25.5M | $25.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.24B | $4.18B | $3.98B | $4.56B | $4.77B | $4.81B |
| Total assets | $9.00B | $9.15B | $9.21B | $9.86B | $10.24B | $10.50B |
| Total liabilities | $4.73B | $4.65B | $4.53B | $5.11B | $5.35B | $5.35B |
| Shareholders' equity | $4.27B | $4.49B | $4.67B | $4.74B | $4.88B | $5.14B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology